Identification of SUPT3H as a novel 8q24/MYC partner in blastic plasmacytoid dendritic cell neoplasm with t(6;8)(p21;q24) translocation

Blood Cancer J. 2015 Apr 10;5(4):e301. doi: 10.1038/bcj.2015.26.

Authors

Y Nakamura¹, H Kayano², E Kakegawa¹, H Miyazaki², T Nagai², Y Uchida¹, Y Ito¹, N Wakimoto¹, S Mori¹, M Bessho¹

Affiliations

¹ Department of Hematology, Saitama Medical University, Saitama, Japan.
² Department of Pathology, Saitama Medical University, Saitama, Japan.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Chromosomes, Human, Pair 6 / genetics
Chromosomes, Human, Pair 8 / genetics
Dendritic Cells / pathology*
Gene Expression Regulation, Neoplastic
Hematologic Neoplasms / etiology
Hematologic Neoplasms / genetics*
Hematologic Neoplasms / pathology
Humans
Male
Proto-Oncogene Proteins c-myc / genetics
RNA, Long Noncoding / genetics
Transcription Factors / genetics*
Transcription Factors / isolation & purification
Translocation, Genetic / genetics*

Substances

MYC protein, human
PVT1 long-non-coding RNA, human
Proto-Oncogene Proteins c-myc
RNA, Long Noncoding
SUPT3H protein, human
Transcription Factors